Story perspectives

Eli Lilly Files Six Lawsuits to Halt Illegal Retatrutide Sales

8/12/2026

Summary

Story summary

Eli Lilly filed six lawsuits on August 12, 2026 against Aesthetic Envy, Astra Peptides and others for selling retatrutide.
Lilly reported over 14,000 retatrutide listings and referred more than 200 people to the FDA and Justice Department.
U.S. Customs seized 690 shipments (31,000 units) of drugs and 1,400 shipments (90,000 vials) in July.
Lilly urged online platforms, e-commerce sites, payment processors and shippers to block retatrutide sales as a crisis.

1 of 1

Story summary

Eli Lilly filed six lawsuits on August 12, 2026 against Aesthetic Envy, Astra Peptides and others for selling retatrutide.
Lilly reported over 14,000 retatrutide listings and referred more than 200 people to the FDA and Justice Department.
U.S. Customs seized 690 shipments (31,000 units) of drugs and 1,400 shipments (90,000 vials) in July.
Lilly urged online platforms, e-commerce sites, payment processors and shippers to block retatrutide sales as a crisis.